140 related articles for article (PubMed ID: 11895376)
1. Neurofilament-immunoreactive neurons in Alzheimer's disease and dementia with Lewy bodies.
Shepherd CE; McCann H; Thiel E; Halliday GM
Neurobiol Dis; 2002 Mar; 9(2):249-57. PubMed ID: 11895376
[TBL] [Abstract][Full Text] [Related]
2. Neurofilament-immunoreactive neurons are not selectively vulnerable in Alzheimer's disease.
Shepherd CE; Thiel E; McCann H; Halliday GM
Neurobiol Dis; 2001 Feb; 8(1):136-46. PubMed ID: 11162247
[TBL] [Abstract][Full Text] [Related]
3. Depletion of cholinergic neurons in the nucleus of the medial septum and the vertical limb of the diagonal band in dementia with Lewy bodies.
Fujishiro H; Umegaki H; Isojima D; Akatsu H; Iguchi A; Kosaka K
Acta Neuropathol; 2006 Feb; 111(2):109-14. PubMed ID: 16421740
[TBL] [Abstract][Full Text] [Related]
4. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology.
Teaktong T; Graham AJ; Court JA; Perry RH; Jaros E; Johnson M; Hall R; Perry EK
J Neurol Sci; 2004 Oct; 225(1-2):39-49. PubMed ID: 15465084
[TBL] [Abstract][Full Text] [Related]
5. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
Beyer MK; Larsen JP; Aarsland D
Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
[TBL] [Abstract][Full Text] [Related]
6. The cellular basis for the relative resistance of parvalbumin and calretinin immunoreactive neocortical neurons to the pathology of Alzheimer's disease.
Sampson VL; Morrison JH; Vickers JC
Exp Neurol; 1997 May; 145(1):295-302. PubMed ID: 9184132
[TBL] [Abstract][Full Text] [Related]
7. Differences in magnetization transfer ratios of the hippocampus between dementia with Lewy bodies and Alzheimer's disease.
Hanyu H; Shimizu S; Tanaka Y; Kanetaka H; Iwamoto T; Abe K
Neurosci Lett; 2005 May 20-27; 380(1-2):166-9. PubMed ID: 15854771
[TBL] [Abstract][Full Text] [Related]
8. Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: stereologic analysis of prefrontal cortex area 9.
Bussière T; Giannakopoulos P; Bouras C; Perl DP; Morrison JH; Hof PR
J Comp Neurol; 2003 Aug; 463(3):281-302. PubMed ID: 12820162
[TBL] [Abstract][Full Text] [Related]
9. Differences between Alzheimer's disease and dementia with Lewy bodies: an fMRI study of task-related brain activity.
Sauer J; ffytche DH; Ballard C; Brown RG; Howard R
Brain; 2006 Jul; 129(Pt 7):1780-8. PubMed ID: 16670180
[TBL] [Abstract][Full Text] [Related]
10. [DaT-SCAN SPECT in the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease].
Vaamonde-Gamo J; Flores-Barragán JM; Ibáñez R; Gudín M; Hernández A
Rev Neurol; 2005 Sep 1-15; 41(5):276-9. PubMed ID: 16138284
[TBL] [Abstract][Full Text] [Related]
11. Neuronal hemoglobin is reduced in Alzheimer's disease, argyrophilic grain disease, Parkinson's disease, and dementia with Lewy bodies.
Ferrer I; Gómez A; Carmona M; Huesa G; Porta S; Riera-Codina M; Biagioli M; Gustincich S; Aso E
J Alzheimers Dis; 2011; 23(3):537-50. PubMed ID: 21157025
[TBL] [Abstract][Full Text] [Related]
12. Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes.
Albasanz JL; Dalfó E; Ferrer I; Martín M
Neurobiol Dis; 2005 Dec; 20(3):685-93. PubMed ID: 15949941
[TBL] [Abstract][Full Text] [Related]
13. Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease using cortical pattern matching: diagnosis and gender effects.
Ballmaier M; O'Brien JT; Burton EJ; Thompson PM; Rex DE; Narr KL; McKeith IG; DeLuca H; Toga AW
Neuroimage; 2004 Sep; 23(1):325-35. PubMed ID: 15325380
[TBL] [Abstract][Full Text] [Related]
14. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease.
Orimo S; Amino T; Itoh Y; Takahashi A; Kojo T; Uchihara T; Tsuchiya K; Mori F; Wakabayashi K; Takahashi H
Acta Neuropathol; 2005 Jun; 109(6):583-8. PubMed ID: 15933869
[TBL] [Abstract][Full Text] [Related]
15. Dementia with Lewy bodies.
McKeith IG; Burn DJ; Ballard CG; Collerton D; Jaros E; Morris CM; McLaren A; Perry EK; Perry R; Piggott MA; O'Brien JT
Semin Clin Neuropsychiatry; 2003 Jan; 8(1):46-57. PubMed ID: 12567332
[TBL] [Abstract][Full Text] [Related]
16. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
17. The medial temporal lobe in dementia with Lewy bodies: a comparative study with Alzheimer's disease.
Lippa CF; Johnson R; Smith TW
Ann Neurol; 1998 Jan; 43(1):102-6. PubMed ID: 9450774
[TBL] [Abstract][Full Text] [Related]
18. alpha-Internexin immunoreactivity reflects variable neuronal vulnerability in Alzheimer's disease and supports the role of the beta-amyloid plaques in inducing neuronal injury.
Dickson TC; Chuckowree JA; Chuah MI; West AK; Vickers JC
Neurobiol Dis; 2005 Mar; 18(2):286-95. PubMed ID: 15686957
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease.
Gómez-Tortosa E; Gonzalo I; Fanjul S; Sainz MJ; Cantarero S; Cemillán C; Yébenes JG; del Ser T
Arch Neurol; 2003 Sep; 60(9):1218-22. PubMed ID: 12975286
[TBL] [Abstract][Full Text] [Related]
20. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
